Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...

International biotechnology company GlaxoSmithKline is moving its ... step to strengthen its presence in the Greater Boston area. The research and development teams will relocate from Rockville ...

Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...

With a distinguished career in immunology and infectious diseases, Dr Screaton's expertise aligns with GSK's scientific research focus areas. He holds several prestigious positions, including ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...

UK drugmaker GSK is struggling to convince the market that ... particularly in speciality medicines and in areas like oncology.” The drugmaker does not have one potential mega blockbuster ...

The pharmaceutical industry faces significantly longer lead times than other industries, and time delays can seriously impact the health outcomes of countless individuals. Recognizing the potential ...

In April 2016, we entered into a platform technology transfer and license agreement with GSK to research ... therapeutics targeting novel pathways in areas of significant unmet medical need.

But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...